Clearbridge Biomedics
Medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD39—59m (Dealroom.co estimates Mar 2013.)
Singapore Singapore (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
SGD8.7m | Series B | ||
Total Funding | AUD9.9m |
Related Content
Recent News about Clearbridge Biomedics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.